4-Fluoro-2-methoxyphenol, an apocynin analog with enhanced inhibitory effect on leukocyte oxidant production and phagocytosis
Autor(a) principal: | |
---|---|
Data de Publicação: | 2011 |
Outros Autores: | , , , |
Tipo de documento: | Artigo |
Idioma: | eng |
Título da fonte: | Repositório Institucional da UNESP |
Texto Completo: | http://dx.doi.org/10.1016/j.ejphar.2011.03.043 http://hdl.handle.net/11449/8788 |
Resumo: | Apocynin, a methoxy-substituted catechol (4-hydroxy-3-methoxyacetophenone), originally extracted from the roots of Picrorhiza kurroa, has been extensively used as a non-toxic inhibitor of the multienzymatic complex NADPH oxidase. We discovered that the analogous methoxy-substituted catechol, 4-Fluoro-2-methoxyphenol (F-apocynin), in which the acetyl group present in apocynin was changed to a fluorine atom, was significantly more potent as an inhibitor of NADPH oxidase activity, myeloperoxidase (MPO) chlorinating activity and phagocytosis of microorganisms by neutrophils; it was also as potent as apocynin in inhibiting tumor necrosis factor-alpha (TNF alpha) release by peripheral blood mononuclear cells. We attribute the increased potency of F-apocynin to its increased lipophilicity, which could facilitate the passage of the drug through the cell membrane. The inhibition of MPO chlorination activity, phagocytosis and TNF alpha release shows that apocynin and F-apocynin actions are not restricted to reactive oxygen species inhibition, but further studies are needed to clarify if these mechanisms are related. Like apocynin, F-apocynin did not show cell toxicity, and is a strong candidate for use in the treatment of inflammatory diseases. (C) 2011 Elsevier B.V. All rights reserved. |
id |
UNSP_2b270e04a656d92644576e79c365df55 |
---|---|
oai_identifier_str |
oai:repositorio.unesp.br:11449/8788 |
network_acronym_str |
UNSP |
network_name_str |
Repositório Institucional da UNESP |
repository_id_str |
2946 |
spelling |
4-Fluoro-2-methoxyphenol, an apocynin analog with enhanced inhibitory effect on leukocyte oxidant production and phagocytosisApocyninNeutrophilMyeloperoxidaseNADPH oxidaseTNF alphaPhagocytosisApocynin, a methoxy-substituted catechol (4-hydroxy-3-methoxyacetophenone), originally extracted from the roots of Picrorhiza kurroa, has been extensively used as a non-toxic inhibitor of the multienzymatic complex NADPH oxidase. We discovered that the analogous methoxy-substituted catechol, 4-Fluoro-2-methoxyphenol (F-apocynin), in which the acetyl group present in apocynin was changed to a fluorine atom, was significantly more potent as an inhibitor of NADPH oxidase activity, myeloperoxidase (MPO) chlorinating activity and phagocytosis of microorganisms by neutrophils; it was also as potent as apocynin in inhibiting tumor necrosis factor-alpha (TNF alpha) release by peripheral blood mononuclear cells. We attribute the increased potency of F-apocynin to its increased lipophilicity, which could facilitate the passage of the drug through the cell membrane. The inhibition of MPO chlorination activity, phagocytosis and TNF alpha release shows that apocynin and F-apocynin actions are not restricted to reactive oxygen species inhibition, but further studies are needed to clarify if these mechanisms are related. Like apocynin, F-apocynin did not show cell toxicity, and is a strong candidate for use in the treatment of inflammatory diseases. (C) 2011 Elsevier B.V. All rights reserved.Fundação de Amparo à Pesquisa do Estado de São Paulo (FAPESP)Conselho Nacional de Desenvolvimento Científico e Tecnológico (CNPq)Univ Estadual Paulista, UNESP, Fac Ciencias, Dept Quim, Bauru, SP, BrazilUniv São Paulo, Inst Ciencias Biomed, BR-05508000 São Paulo, BrazilUniv Estadual Paulista, UNESP, Fac Ciencias, Dept Quim, Bauru, SP, BrazilFAPESP: 08/53458-6Elsevier B.V.Universidade Estadual Paulista (Unesp)Universidade de São Paulo (USP)de Almeida, Ana Carolina [UNESP]Marques, Otavio CabralArslanian, ChristinaCondino-Neto, AntonioXimenes, Valdecir Farias [UNESP]2014-05-20T13:26:59Z2014-05-20T13:26:59Z2011-06-25info:eu-repo/semantics/publishedVersioninfo:eu-repo/semantics/article445-453application/pdfhttp://dx.doi.org/10.1016/j.ejphar.2011.03.043European Journal of Pharmacology. Amsterdam: Elsevier B.V., v. 660, n. 2-3, p. 445-453, 2011.0014-2999http://hdl.handle.net/11449/878810.1016/j.ejphar.2011.03.043WOS:000291623600028WOS000291623600028.pdf4066413997908572Web of Sciencereponame:Repositório Institucional da UNESPinstname:Universidade Estadual Paulista (UNESP)instacron:UNESPengEuropean Journal of Pharmacology3.0401,057info:eu-repo/semantics/openAccess2024-04-29T18:16:45Zoai:repositorio.unesp.br:11449/8788Repositório InstitucionalPUBhttp://repositorio.unesp.br/oai/requestopendoar:29462024-08-05T14:20:34.373575Repositório Institucional da UNESP - Universidade Estadual Paulista (UNESP)false |
dc.title.none.fl_str_mv |
4-Fluoro-2-methoxyphenol, an apocynin analog with enhanced inhibitory effect on leukocyte oxidant production and phagocytosis |
title |
4-Fluoro-2-methoxyphenol, an apocynin analog with enhanced inhibitory effect on leukocyte oxidant production and phagocytosis |
spellingShingle |
4-Fluoro-2-methoxyphenol, an apocynin analog with enhanced inhibitory effect on leukocyte oxidant production and phagocytosis de Almeida, Ana Carolina [UNESP] Apocynin Neutrophil Myeloperoxidase NADPH oxidase TNF alpha Phagocytosis |
title_short |
4-Fluoro-2-methoxyphenol, an apocynin analog with enhanced inhibitory effect on leukocyte oxidant production and phagocytosis |
title_full |
4-Fluoro-2-methoxyphenol, an apocynin analog with enhanced inhibitory effect on leukocyte oxidant production and phagocytosis |
title_fullStr |
4-Fluoro-2-methoxyphenol, an apocynin analog with enhanced inhibitory effect on leukocyte oxidant production and phagocytosis |
title_full_unstemmed |
4-Fluoro-2-methoxyphenol, an apocynin analog with enhanced inhibitory effect on leukocyte oxidant production and phagocytosis |
title_sort |
4-Fluoro-2-methoxyphenol, an apocynin analog with enhanced inhibitory effect on leukocyte oxidant production and phagocytosis |
author |
de Almeida, Ana Carolina [UNESP] |
author_facet |
de Almeida, Ana Carolina [UNESP] Marques, Otavio Cabral Arslanian, Christina Condino-Neto, Antonio Ximenes, Valdecir Farias [UNESP] |
author_role |
author |
author2 |
Marques, Otavio Cabral Arslanian, Christina Condino-Neto, Antonio Ximenes, Valdecir Farias [UNESP] |
author2_role |
author author author author |
dc.contributor.none.fl_str_mv |
Universidade Estadual Paulista (Unesp) Universidade de São Paulo (USP) |
dc.contributor.author.fl_str_mv |
de Almeida, Ana Carolina [UNESP] Marques, Otavio Cabral Arslanian, Christina Condino-Neto, Antonio Ximenes, Valdecir Farias [UNESP] |
dc.subject.por.fl_str_mv |
Apocynin Neutrophil Myeloperoxidase NADPH oxidase TNF alpha Phagocytosis |
topic |
Apocynin Neutrophil Myeloperoxidase NADPH oxidase TNF alpha Phagocytosis |
description |
Apocynin, a methoxy-substituted catechol (4-hydroxy-3-methoxyacetophenone), originally extracted from the roots of Picrorhiza kurroa, has been extensively used as a non-toxic inhibitor of the multienzymatic complex NADPH oxidase. We discovered that the analogous methoxy-substituted catechol, 4-Fluoro-2-methoxyphenol (F-apocynin), in which the acetyl group present in apocynin was changed to a fluorine atom, was significantly more potent as an inhibitor of NADPH oxidase activity, myeloperoxidase (MPO) chlorinating activity and phagocytosis of microorganisms by neutrophils; it was also as potent as apocynin in inhibiting tumor necrosis factor-alpha (TNF alpha) release by peripheral blood mononuclear cells. We attribute the increased potency of F-apocynin to its increased lipophilicity, which could facilitate the passage of the drug through the cell membrane. The inhibition of MPO chlorination activity, phagocytosis and TNF alpha release shows that apocynin and F-apocynin actions are not restricted to reactive oxygen species inhibition, but further studies are needed to clarify if these mechanisms are related. Like apocynin, F-apocynin did not show cell toxicity, and is a strong candidate for use in the treatment of inflammatory diseases. (C) 2011 Elsevier B.V. All rights reserved. |
publishDate |
2011 |
dc.date.none.fl_str_mv |
2011-06-25 2014-05-20T13:26:59Z 2014-05-20T13:26:59Z |
dc.type.status.fl_str_mv |
info:eu-repo/semantics/publishedVersion |
dc.type.driver.fl_str_mv |
info:eu-repo/semantics/article |
format |
article |
status_str |
publishedVersion |
dc.identifier.uri.fl_str_mv |
http://dx.doi.org/10.1016/j.ejphar.2011.03.043 European Journal of Pharmacology. Amsterdam: Elsevier B.V., v. 660, n. 2-3, p. 445-453, 2011. 0014-2999 http://hdl.handle.net/11449/8788 10.1016/j.ejphar.2011.03.043 WOS:000291623600028 WOS000291623600028.pdf 4066413997908572 |
url |
http://dx.doi.org/10.1016/j.ejphar.2011.03.043 http://hdl.handle.net/11449/8788 |
identifier_str_mv |
European Journal of Pharmacology. Amsterdam: Elsevier B.V., v. 660, n. 2-3, p. 445-453, 2011. 0014-2999 10.1016/j.ejphar.2011.03.043 WOS:000291623600028 WOS000291623600028.pdf 4066413997908572 |
dc.language.iso.fl_str_mv |
eng |
language |
eng |
dc.relation.none.fl_str_mv |
European Journal of Pharmacology 3.040 1,057 |
dc.rights.driver.fl_str_mv |
info:eu-repo/semantics/openAccess |
eu_rights_str_mv |
openAccess |
dc.format.none.fl_str_mv |
445-453 application/pdf |
dc.publisher.none.fl_str_mv |
Elsevier B.V. |
publisher.none.fl_str_mv |
Elsevier B.V. |
dc.source.none.fl_str_mv |
Web of Science reponame:Repositório Institucional da UNESP instname:Universidade Estadual Paulista (UNESP) instacron:UNESP |
instname_str |
Universidade Estadual Paulista (UNESP) |
instacron_str |
UNESP |
institution |
UNESP |
reponame_str |
Repositório Institucional da UNESP |
collection |
Repositório Institucional da UNESP |
repository.name.fl_str_mv |
Repositório Institucional da UNESP - Universidade Estadual Paulista (UNESP) |
repository.mail.fl_str_mv |
|
_version_ |
1808128349807050752 |